<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03126084</url>
  </required_header>
  <id_info>
    <org_study_id>ANES-QLB-0609</org_study_id>
    <nct_id>NCT03126084</nct_id>
  </id_info>
  <brief_title>Postoperative Effects of TAP Block Versus QLB Type 2 Block</brief_title>
  <official_title>Comparison of Postoperative Analgesic Effects of Transversus Abdominis Plane Block and Quadratus Lumborum Block Type 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bozyaka Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bozyaka Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares analgesic effectiveness of transversus abdominis plane block and
      quadratus lumborum block type 2 in open hernia repair surgery. All of the patients will
      receive routine intravenous analgesic regimen. In addition to that one-third of the patients
      will receive transversus abdominis plane block, one-third will receive quadratus lumborum
      block type 2. One-third of the patients will not receive any blocks and will constitute the
      control group
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Actual">November 11, 2017</completion_date>
  <primary_completion_date type="Actual">November 11, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Postoperative pain intensity according Numeric Rating Scale between 0-10 (0=no pain, 10=worst pain ever</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>2 hours after surgery</time_frame>
    <description>Postoperative pain intensity according Numeric Rating Scale between 0-10 (0=no pain, 10=worst pain ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>6 hours after surgery</time_frame>
    <description>Postoperative pain intensity according Numeric Rating Scale between 0-10 (0=no pain, 10=worst pain ever</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Postoperative pain intensity according Numeric Rating Scale between 0-10 (0=no pain, 10=worst pain ever</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>TAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose.
Patients will receive transversus abdominis plane block with 20 ml of 0.25% bupivacaine preoperatively, in addition to intravenous acetaminophen 1000mg twice a day for postoperative analgesia.
Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>QLB2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose.
Patients will receive quadratus lumborum type 2 block with 20 ml of %0.25 bupivacaine preoperatively, in addition to intravenous acetaminophen 1000mg twice a day for postoperative analgesia.
Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose.
Patients will receive intravenous acetaminophen 1000mg twice a day for postoperative analgesia.
Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>1000 mg of intravenous acetaminophen will be administered twice a day</description>
    <arm_group_label>TAP</arm_group_label>
    <arm_group_label>QLB2</arm_group_label>
    <arm_group_label>CONT</arm_group_label>
    <other_name>Postoperative routine analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25% Bupivacaine</intervention_name>
    <description>20 ml of 0.25% bupivacaine will be administered to the fascia of the transversus abdominis muscle under ultrasound guidance.</description>
    <arm_group_label>TAP</arm_group_label>
    <other_name>Transversus abdominis plane block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5% Bupivacaine+Glucose</intervention_name>
    <description>15mg of 0.5% bupivacaine will be administered to subarachnoid space through 25G spinal needle</description>
    <arm_group_label>TAP</arm_group_label>
    <arm_group_label>QLB2</arm_group_label>
    <arm_group_label>CONT</arm_group_label>
    <other_name>Subarachnoid Block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol HCl</intervention_name>
    <description>50mg of intramuscular tramadol will be administered when pain score is greater than 3 according to NRS</description>
    <arm_group_label>TAP</arm_group_label>
    <arm_group_label>QLB2</arm_group_label>
    <arm_group_label>CONT</arm_group_label>
    <other_name>Postoperative Salvage Analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Inguinal Hernia Repair</intervention_name>
    <description>Patients will undergo open inguinal hernia repair with one of the tension free mesh techniques</description>
    <arm_group_label>TAP</arm_group_label>
    <arm_group_label>QLB2</arm_group_label>
    <arm_group_label>CONT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25% Bupivacaine</intervention_name>
    <description>10 ml 0.25% bupivacaine will be administered quadratus lumborum muscle and erector spinae muscle</description>
    <arm_group_label>QLB2</arm_group_label>
    <other_name>Quadratus lumborum block type 2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are over 18 years of age

          -  Patients who are scheduled for elective unilateral open hernia repair with tension
             free mesh techniques

          -  Patients who are in ASA's physical status score group 1 or 2

        Exclusion Criteria:

          -  Patients who are younger than 18 years of age

          -  Patients who have severe stenotic heart diseases

          -  Patients who have bleeding diathesis

          -  Patients who have true allergies to local anesthetics

          -  Patients who have neurologic deficits corresponding to effect site of the anesthetic
             techniques
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeki T TEKGUL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Izmir Bozyaka Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Izmir Bozyaka Training and Research Hospital</name>
      <address>
        <city>Izmir</city>
        <zip>35170</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. Erratum in: Anesth Analg. 2007 May;104(5):1108.</citation>
    <PMID>17179269</PMID>
  </reference>
  <reference>
    <citation>Bærentzen F, Maschmann C, Jensen K, Belhage B, Hensler M, Børglum J. Ultrasound-guided nerve block for inguinal hernia repair: a randomized, controlled, double-blind study. Reg Anesth Pain Med. 2012 Sep-Oct;37(5):502-7. doi: 10.1097/AAP.0b013e31825a3c8a.</citation>
    <PMID>22705951</PMID>
  </reference>
  <reference>
    <citation>Finnerty O, Carney J, McDonnell JG. Trunk blocks for abdominal surgery. Anaesthesia. 2010 Apr;65 Suppl 1:76-83. doi: 10.1111/j.1365-2044.2009.06203.x. Review.</citation>
    <PMID>20377549</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>November 11, 2017</last_update_submitted>
  <last_update_submitted_qc>November 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

